Edilio Borroni

发表

Pre-clinical characterization of [11C]R05013853 as a novel radiotracer for imaging of the glycine transporter type 1 by positron emission tomography

Anil Kumar, Yun Zhou, Dean F. Wong, 2013, NeuroImage.

Characterization of [11C]RO5013853, a novel PET tracer for the glycine transporter type 1 (GlyT1) in humans

Anil Kumar, Yun Zhou, Dean F. Wong, 2013, NeuroImage.

First in-human PET study of 3 novel tau radiopharmaceuticals: [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948

Dean F. Wong, Hiroto Kuwabara, Robert A. Comley, 2015, Alzheimer's & Dementia.

Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal–lesioned rats: reversal by glycine and a glycine transporter inhibitor

Edilio Borroni, Daniela Alberati, J. Kew, 2003, Biological Psychiatry.

Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice

Edilio Borroni, Michael Honer, E. Arrigoni, 2011, Proceedings of the National Academy of Sciences.

Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors.

Markus Bender, Edilio Borroni, Daniela Alberati, 2010, Bioorganic & medicinal chemistry letters.

Molecular recognition at the active site of catechol-o-methyltransferase: energetically favorable replacement of a water molecule imported by a bisubstrate inhibitor.

Edilio Borroni, Christian Lerner, François Diederich, 2009, Angewandte Chemie.

Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia.

Alexander Alanine, Markus Bender, Edilio Borroni, 2010, Journal of medicinal chemistry.

Application of cross-species PET imaging to assess neurotransmitter release in brain

Christer Halldin, Lars Farde, Sjoerd J. Finnema, 2015, Psychopharmacology.

Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 A resolution.

Francis Müller, Edilio Borroni, Daniel Schlatter, 2005, Acta crystallographica. Section D, Biological crystallography.

Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia

Götz Schlotterbeck, Edilio Borroni, Daniela Alberati, 2012, Neuropharmacology.

Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.

Hideo Fujiwara, Takeshi Iwatsubo, John Q. Trojanowski, 2002, The Journal of clinical investigation.